Skylands Capital, LLC Simulations Plus, Inc. Transaction History

Skylands Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Jul 24, 2018	SELL	$14.65 - $23.75 $468,800 - $760,000	-32,000 Closed	0 $0
Q1 2018 Apr 19, 2018	SELL	$14.4 - $16.8 $395,424 - $461,328	-27,460 Reduced 46.18%	32,000 $472,000
Q4 2017 Jan 16, 2018	SELL	$15.3 - $17.4 $971,397 - $1.1 Million	-63,490 Reduced 51.64%	59,460 $957,000
Q3 2017 Oct 19, 2017	BUY	$13.7 - $15.65 $1.68 Million - $1.92 Million	122,950	122,950 $1.91 Million

172

15.1M

5.4K

1.4K

Ticker SLP
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 20,297,700
Market Cap $607M
Description
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...

Get notified when there are updates to the investment portfolio of Skylands Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Skylands Capital, LLC with notifications on news.